{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:26:29Z","timestamp":1786987589244,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ctim.2020.102394","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T09:58:15Z","timestamp":1589191095000},"page":"102394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Integrative approaches to treating pain in sickle cell disease: Pre-clinical and clinical evidence"],"prefix":"10.1016","volume":"51","author":[{"given":"Varun","family":"Sagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donovan A","family":"Argueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Kiven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpna","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4537","key":"10.1016\/j.ctim.2020.102394_bib0005","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/178792a0","article-title":"A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin","volume":"178","author":"Ingram","year":"1956","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.ctim.2020.102394_bib0010","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2012-04-383430","article-title":"Sickle cell pain: a critical reappraisal","volume":"120","author":"Ballas","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ctim.2020.102394_bib0015","series-title":"Sickle Cell Pain","author":"Ballas","year":"2014"},{"issue":"10091","key":"10.1016\/j.ctim.2020.102394_bib0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ctim.2020.102394_bib0025","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ctim.2020.102394_bib0030","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J Clin Invest"},{"issue":"16","key":"10.1016\/j.ctim.2020.102394_bib0035","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.ctim.2020.102394_bib0040","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1182\/blood-2017-02-765891","article-title":"Treating sickle cell disease by targeting HbS polymerization","volume":"129","author":"Eaton","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ctim.2020.102394_bib0045","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/540154","article-title":"Morphine for the treatment of pain in sickle cell disease","volume":"2015","author":"Gupta","year":"2015","journal-title":"Sci World J"},{"issue":"22","key":"10.1016\/j.ctim.2020.102394_bib0050","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1182\/blood-2017-05-782003","article-title":"Targeting novel mechanisms of pain in sickle cell disease","volume":"130","author":"Tran","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ctim.2020.102394_bib0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ctim.2020.102394_bib0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neulet.2019.02.008","article-title":"Immune cell neural interactions and their contributions to sickle cell disease","volume":"699","author":"Sagi","year":"2019","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.ctim.2020.102394_bib0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajh.23341","article-title":"Patients with sickle cell disease have increased sensitivity to cold and heat","volume":"88","author":"Brandow","year":"2013","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.ctim.2020.102394_bib0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2141.2011.08977.x","article-title":"Mouse models for studying pain in sickle disease: Effects of strain, age, and acuteness","volume":"156","author":"Cain","year":"2012","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.ctim.2020.102394_bib0075","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpain.2016.01.475","article-title":"An evaluation of central sensitization in patients with sickle cell disease","volume":"17","author":"Campbell","year":"2016","journal-title":"J Pain"},{"issue":"12","key":"10.1016\/j.ctim.2020.102394_bib0080","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood-2010-12-327429","article-title":"Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease","volume":"118","author":"Hillery","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ctim.2020.102394_bib0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2010-01-260372","article-title":"Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids","volume":"116","author":"Kohli","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ctim.2020.102394_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160608","article-title":"Comparative analysis of pain behaviours in humanized mouse models of sickle cell anemia","volume":"11","author":"Lei","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ctim.2020.102394_bib0095","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/pbc.25574","article-title":"Early insights into the neurobiology of pain in sickle cell disease: a systematic review of the literature","volume":"62","author":"Brandow","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.ctim.2020.102394_bib0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/MPH.0000000000000214","article-title":"Sensory and thermal quantitative testing in children with sickle cell disease","volume":"37","author":"Jacob","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.ctim.2020.102394_bib0105","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1002\/cpns.54","article-title":"Mouse models of pain in sickle cell disease","volume":"85","author":"Sagi","year":"2018","journal-title":"Curr Protoc Neurosci"},{"issue":"2","key":"10.1016\/j.ctim.2020.102394_bib0110","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.3324\/haematol.2015.137489","article-title":"Spinal glial activation and oxidative stress are alleviated by treatment with curcumin or coenzyme Q in sickle mice","volume":"101","author":"Valverde","year":"2016","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.ctim.2020.102394_bib0115","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1182\/blood-2013-04-498105","article-title":"Mast cell activation contributes to sickle cell pathobiology and pain in mice","volume":"122","author":"Vincent","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ctim.2020.102394_bib0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/bjh.14300","article-title":"Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use","volume":"175","author":"Brandow","year":"2016","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.ctim.2020.102394_bib0125","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ajh.21995","article-title":"Plasma glial fibrillary acidic protein levels in children with sickle cell disease","volume":"86","author":"Savage","year":"2011","journal-title":"Am J Hematol"},{"issue":"1\u20132","key":"10.1016\/j.ctim.2020.102394_bib0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pain.2009.07.008","article-title":"Climatic and geographic temporal patterns of pain in the multicenter study of hydroxyurea","volume":"146","author":"Smith","year":"2009","journal-title":"Pain"},{"issue":"9757","key":"10.1016\/j.ctim.2020.102394_bib0135","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ctim.2020.102394_bib0140","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/asheducation-2013.1.362","article-title":"Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies","volume":"2013","author":"Manwani","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1016\/j.ctim.2020.102394_bib0145","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-2143(97)90005-6","article-title":"Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia","volume":"129","author":"Wun","year":"1997","journal-title":"J Lab Clin Med"},{"issue":"12","key":"10.1016\/j.ctim.2020.102394_bib0150","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1161\/ATVBAHA.110.211615","article-title":"P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease","volume":"30","author":"Polanowska-Grabowska","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.ctim.2020.102394_bib0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.blre.2006.06.001","article-title":"Platelet-neutrophil-interactions: linking hemostasis and inflammation","volume":"21","author":"Zarbock","year":"2007","journal-title":"Blood Rev"},{"issue":"6","key":"10.1016\/j.ctim.2020.102394_bib0160","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1182\/blood.V98.6.1955","article-title":"P-selectin mediates the adhesion of sickle erythrocytes to the endothelium","volume":"98","author":"Matsui","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ctim.2020.102394_bib0165","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1182\/blood.V92.7.2551","article-title":"Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis","volume":"92","author":"Graido-Gonzalez","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ctim.2020.102394_bib0170","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1365-2141.1994.tb08318.x","article-title":"Circulating cytokines in sickle cell patients during steady state","volume":"87","author":"Croizat","year":"1994","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.ctim.2020.102394_bib0175","first-page":"611","article-title":"Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease","volume":"84","author":"Francis","year":"1992","journal-title":"J Natl Med Assoc"},{"issue":"2","key":"10.1016\/j.ctim.2020.102394_bib0180","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1189\/jlb.0708445","article-title":"Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy","volume":"85","author":"Lanaro","year":"2009","journal-title":"J Leukoc Biol"},{"issue":"5","key":"10.1016\/j.ctim.2020.102394_bib0185","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3324\/haematol.2015.136523","article-title":"Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation","volume":"101","author":"Vincent","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.ctim.2020.102394_bib0190","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/imr.12622","article-title":"Mast cell-neural interactions contribute to pain and itch","volume":"282","author":"Gupta","year":"2018","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.ctim.2020.102394_bib0195","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/j.pain.0000000000000104","article-title":"Sensitization of nociceptive spinal neurons contributes to pain in a transgenic model of sickle cell disease","volume":"156","author":"Cataldo","year":"2015","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.ctim.2020.102394_bib0200","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jpain.2015.07.005","article-title":"Frequency of hospitalizations for pain and association with altered brain network connectivity in sickle cell disease","volume":"16","author":"Darbari","year":"2015","journal-title":"J Pain"},{"issue":"9","key":"10.1016\/j.ctim.2020.102394_bib0205","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/j.pain.0000000000000966","article-title":"Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis","volume":"158","author":"Uhelski","year":"2017","journal-title":"Pain"},{"issue":"23","key":"10.1016\/j.ctim.2020.102394_bib0210","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1182\/bloodadvances.2017006940","article-title":"Depression, quality of life, and medical resource utilization in sickle cell disease","volume":"1","author":"Adam","year":"2017","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.ctim.2020.102394_bib0215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpain.2004.11.001","article-title":"Human brain mechanisms of pain perception and regulation in health and disease","volume":"9","author":"Apkarian","year":"2005","journal-title":"Eur J Pain"},{"issue":"2","key":"10.1016\/j.ctim.2020.102394_bib0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12291-012-0277-9","article-title":"Hematological parameters and RBC TBARS level of q 10 supplemented tribal sickle cell patients: a hospital based study","volume":"28","author":"Thakur","year":"2013","journal-title":"Indian J Clin Biochem"},{"issue":"1","key":"10.1016\/j.ctim.2020.102394_bib0225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","article-title":"Therapeutic roles of curcumin: lessons learned from clinical trials","volume":"15","author":"Gupta","year":"2013","journal-title":"AAPS J"},{"issue":"6","key":"10.1016\/j.ctim.2020.102394_bib0230","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00776-014-0633-0","article-title":"Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study","volume":"19","author":"Nakagawa","year":"2014","journal-title":"J Orthop Sci"},{"issue":"4-5","key":"10.1016\/j.ctim.2020.102394_bib0235","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.clinbiochem.2009.10.057","article-title":"Improvement in oxidative stress and antioxidant parameters in beta-thalassemia\/Hb E patients treated with curcuminoids","volume":"43","author":"Kalpravidh","year":"2010","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1016\/j.ctim.2020.102394_bib0240","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-2143(97)90062-7","article-title":"Increased red cell glutamine availability in sickle cell anemia: demonstration of increased active transport, affinity, and increased glutamate level in intact red cells","volume":"130","author":"Niihara","year":"1997","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ctim.2020.102394_bib0245","first-page":"4","article-title":"l-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells","volume":"5","author":"Niihara","year":"2005","journal-title":"BMC Blood Disord"},{"issue":"3","key":"10.1016\/j.ctim.2020.102394_bib0250","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l-glutamine in sickle cell disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ctim.2020.102394_bib0255","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/pbc.24163","article-title":"Micronutrients and sickle cell disease, effects on growth, infection and vaso-occlusive crisis: a systematic review","volume":"59","author":"Dekker","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ctim.2020.102394_bib0260","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1017\/jns.2014.63","article-title":"Body composition and grip strength are improved in transgenic sickle mice fed a high-protein diet","volume":"4","author":"Capers","year":"2015","journal-title":"J Nutr Sci"},{"issue":"8","key":"10.1016\/j.ctim.2020.102394_bib0265","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1177\/1535370214531863","article-title":"High protein diet attenuates histopathologic organ damage and vascular leakage in transgenic murine model of sickle cell anemia","volume":"239","author":"Manci","year":"2014","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"10.1016\/j.ctim.2020.102394_bib0270","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/ajcn\/75.2.300","article-title":"Effect of zinc supplementation on growth and body composition in children with sickle cell disease","volume":"75","author":"Zemel","year":"2002","journal-title":"Am J Clin Nutr"},{"issue":"15","key":"10.1016\/j.ctim.2020.102394_bib0275","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/bloodadvances.2018021444","article-title":"Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)","volume":"2","author":"Daak","year":"2018","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.ctim.2020.102394_bib0280","doi-asserted-by":"crossref","first-page":"H39","DOI":"10.1152\/ajpheart.00162.2008","article-title":"Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress","volume":"295","author":"Kaul","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"10.1016\/j.ctim.2020.102394_bib0285","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3324\/haematol.2013.086637","article-title":"A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes","volume":"98","author":"Morris","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.ctim.2020.102394_bib0290","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2018.208322","article-title":"Diet and gender influence survival of transgenic Berkley sickle cell mice","author":"Jahagirdar","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.ctim.2020.102394_bib0295","doi-asserted-by":"crossref","first-page":"34493","DOI":"10.1038\/srep34493","article-title":"Electroacupuncture in conscious free-moving mice reduces pain by ameliorating peripheral and central nociceptive mechanisms","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ctim.2020.102394_bib0300","doi-asserted-by":"crossref","DOI":"10.2147\/JPR.S210196","article-title":"Substance P modulates electroacupuncture analgesia in humanized mice with sickle cell disease","author":"Wang","year":"2019","journal-title":"J Pain Res"},{"issue":"9","key":"10.1016\/j.ctim.2020.102394_bib0305","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/AJP.0000000000000036","article-title":"A retrospective review of acupuncture use for the treatment of pain in sickle cell disease patients: Descriptive analysis from a single institution","volume":"30","author":"Lu","year":"2014","journal-title":"Clin J Pain"},{"key":"10.1016\/j.ctim.2020.102394_bib0310","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2147\/JPR.S131859","article-title":"The effect of hypnosis on pain and peripheral blood flow in sickle-cell disease: a pilot study","volume":"10","author":"Bhatt","year":"2017","journal-title":"J Pain Res"},{"key":"10.1016\/j.ctim.2020.102394_bib0315","doi-asserted-by":"crossref","first-page":"j1284","DOI":"10.1136\/bmj.j1284","article-title":"Management of chronic pain using complementary and integrative medicine","volume":"357","author":"Chen","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ctim.2020.102394_bib0320","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27525","article-title":"Virtual reality as complementary pain therapy in hospitalized patients with sickle cell disease","volume":"66","author":"Agrawal","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.ctim.2020.102394_bib0325","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jpainsymman.2016.12.351","article-title":"A randomized trial of yoga for children hospitalized with sickle cell vaso-occlusive crisis","volume":"53","author":"Moody","year":"2017","journal-title":"J Pain Symptom Manage"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229920306245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229920306245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:13:50Z","timestamp":1760807630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229920306245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":65,"alternative-id":["S0965229920306245"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2020.102394","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative approaches to treating pain in sickle cell disease: Pre-clinical and clinical evidence","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2020.102394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102394"}}